Edition:
United States

Biogaia AB (BIOGb.ST)

BIOGb.ST on Stockholm Stock Exchange

337.50SEK
16 Feb 2018
Change (% chg)

-1.00kr (-0.30%)
Prev Close
338.50kr
Open
339.50kr
Day's High
339.50kr
Day's Low
336.50kr
Volume
12,879
Avg. Vol
18,366
52-wk High
369.50kr
52-wk Low
278.50kr

Chart for

About

Biogaia AB is a Sweden-based company engaged in the development and sell of probiotic products, primarily based on the Lactobacillus reuteri bacteria. The Company’s activities are divided into three segments: Finished consumer products, which distributes tablets, drops, Oral Rehydration Solutions (ORSs), and oral health... (more)

Overall

Beta: 0.78
Market Cap(Mil.): kr5,601.08
Shares Outstanding(Mil.): 16.60
Dividend: 4.31
Yield (%): 2.67

Financials

  Industry Sector
P/E (TTM): -- 21.75 17.27
EPS (TTM): -- -- --
ROI: -- 12.13 35.43
ROE: -- 15.30 17.10

BRIEF-Biogaia Q4 profit rises, proposes extra dividend

* Q4 NET SALES AMOUNTED TO SEK 170.1 MILLION VS YR-AGO 138.8 MILLION, AN INCREASE OF 23% (EXCLUDING FOREIGN EXCHANGE EFFECTS, 27%)

Feb 08 2018

BRIEF-Biogaia signs deal with Abbott to launch probiotic in China

* SAYS HAS SIGNED AN EXCLUSIVE AGREEMENT WITH ABBOTT FOR RIGHTS TO COMMERCIALIZE BIOGAIA PROTECTIS TABS IN CHINA

Jan 18 2018

BRIEF-Biogaia Q3 operating profit up 11 pct​

* Biogaia says Q3 ‍net sales amounted to 147.7 million SEK(126.0), up 17 pct​

Oct 25 2017

Earnings vs. Estimates